Benefit of Intensive Statin Therapy in Women: Results from PROVE IT-TIMI 22

Por Truong, Quynh A., Murphy, Sabina A, McCabe, Carolyn H., Armani, Annemarie, Cannon, Christopher P.
Publicado em 2011

Dynamic TIMI Risk Score for STEMI

Por Amin, Sameer T., Morrow, David A., Braunwald, Eugene, Sloan, Sarah, Contant, Charles, Murphy, Sabina, Antman, Elliott M.
Publicado em 2013

Central obesity and cardiovascular outcomes in patients with acute coronary syndrome: observations from the MERLIN-TIMI 36 trial

Por Kadakia, Mitul B, Fox, Caroline S, Scirica, Benjamin M, Murphy, Sabina A, Bonaca, Marc P, Morrow, David A
Publicado no Heart (2011)

Influence of Race and Sex on Lipoprotein-Associated Phospholipase A2 Levels: Observations from the Dallas Heart Study

Por Brilakis, Emmanouil S., Khera, Amit, McGuire, Darren K., See, Raphael, Banerjee, Subhash, Murphy, Sabina A., de Lemos, James A.
Publicado em 2007

Evaluation of the diagnostic performance of current and next-generation assays for cardiac troponin I in the BWH-TIMI ED Chest Pain Study

Por Bonaca, Marc P, Ruff, Christian T, Kosowsky, Joshua, Conrad, Michael J, Murphy, Sabina A, Sabatine, Marc S, Jarolim, Petr, Morrow, David A
Publicado em 2013

Diagnostic evaluation of the MRP-8/14 for the emergency assessment of chest pain

Por Vora, Amit N., Bonaca, Marc P., Ruff, Christian T., Jarolim, Petr, Murphy, Sabina, Croce, Kevin, Sabatine, Marc S., Simon, Daniel I., Morrow, David A.
Publicado em 2012

The prognostic significance of cardiac structure and function in atrial fibrillation: the ENGAGE AF-TIMI 48 Echocardiographic Substudy

Por Gupta, Deepak K, Giugliano, Robert P, Ruff, Christian T, Claggett, Brian, Murphy, Sabina, Antman, Elliott, Mercuri, Michele F., Braunwald, Eugene, Solomon, Scott D
Publicado no J Am Soc Echocardiogr (2016)

Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF‐TIMI48 Trial

Por Xu, Haiyan, Ruff, Christian T., Giugliano, Robert P., Murphy, Sabina A., Nordio, Francesco, Patel, Indravadan, Shi, Minggao, Mercuri, Michele, Antman, Elliott M., Braunwald, Eugene
Publicado no J Am Heart Assoc (2016)

Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial

Por Murphy, Sabina A., Antman, Elliott M., Wiviott, Stephen D., Weerakkody, Govinda, Morocutti, Giorgio, Huber, Kurt, Lopez-Sendon, Jose, McCabe, Carolyn H., Braunwald, Eugene
Publicado em 2008

Evaluation of coronary artery calcium screening strategies focused on risk categories: The Dallas Heart Study

Por Patel, Mahesh J., de Lemos, James A., McGuire, Darren K., See, Raphael, Lindsey, Jason B., Murphy, Sabina A., Grundy, Scott M., Khera, Amit
Publicado em 2009

Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes

Por Røysland, Ragnhild, Bonaca, Marc P, Omland, Torbjørn, Sabatine, Marc, Murphy, Sabina A, Scirica, Benjamin M, Bjerre, Mette, Flyvbjerg, Allan, Braunwald, Eugene, Morrow, David A
Publicado em 2012

Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18

Por Morrow, David A., Sabatine, Marc S., Brennan, Marie-Luise, de Lemos, James A., Murphy, Sabina A., Ruff, Christian T., Rifai, Nader, Cannon, Christopher P., Hazen, Stanley L.
Publicado em 2008

Role of ST2 in Non–ST-Elevation Acute Coronary Syndrome in the MERLIN-TIMI 36 Trial

Por Kohli, Payal, Bonaca, Marc P., Kakkar, Rahul, Kudinova, Anastacia Y., Scirica, Benjamin M., Sabatine, Marc S., Murphy, Sabina A., Braunwald, Eugene, Lee, Richard T., Morrow, David A.
Publicado no Clin Chem (2011)

Multimarker Risk Stratification in Patients With Acute Myocardial Infarction

Por O'Donoghue, Michelle L., Morrow, David A., Cannon, Christopher P., Jarolim, Petr, Desai, Nihar R., Sherwood, Matthew W., Murphy, Sabina A., Gerszten, Robert E., Sabatine, Marc S.
Publicado no J Am Heart Assoc (2016)

Universal Classification System Type of Incident Myocardial Infarction in Patients With Stable Atherosclerosis: Observations From Thrombin Receptor Antagonist in Secondary Preventi...

Por Kidd, Stephen K., Bonaca, Marc P., Braunwald, Eugene, De Ferrari, Gaetano M., Lewis, Basil S., Merlini, Piera A., Murphy, Sabina A., Scirica, Benjamin M., White, Harvey D., Morrow, David A.
Publicado no J Am Heart Assoc (2016)

Vorapaxar in Patients With Diabetes Mellitus and Previous Myocardial Infarction: Findings From the Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic...

Por Cavender, Matthew A., Scirica, Benjamin M., Bonaca, Marc P., Angiolillo, Dominick J., Dalby, Anthony J., Dellborg, Mikael, Morais, Joao, Murphy, Sabina A., Ophuis, Ton Oude, Tendera, Michal, Braunwald, Eugene, Morrow, David A.
Publicado no Circulation (2015)

Efficacy and Safety of Vorapaxar as Approved for Clinical Use in the United States

Por Magnani, Giulia, Bonaca, Marc P., Braunwald, Eugene, Dalby, Anthony J., Fox, Keith A. A., Murphy, Sabina A., Nicolau, José Carlos, Oude Ophuis, Ton, Scirica, Benjamin M., Spinar, Jindrich, Theroux, Pierre, Morrow, David A.
Publicado no J Am Heart Assoc (2015)

Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF–TIMI 48 Trial

Por Kato, Eri Toda, Giugliano, Robert P., Ruff, Christian T., Koretsune, Yukihiro, Yamashita, Takeshi, Kiss, Robert Gabor, Nordio, Francesco, Murphy, Sabina A., Kimura, Tetsuya, Jin, James, Lanz, Hans, Mercuri, Michele, Braunwald, Eugene, Antman, Elliott M.
Publicado no J Am Heart Assoc (2016)

Organization and staffing practices in US cardiac intensive care units: a survey on behalf of the American Heart Association Writing Group on the Evolution of Critical Care Cardiol...

Por O’Malley, Ryan G, Olenchock, Benjamin, Bohula-May, Erin, Barnett, Christopher, Fintel, Dan J, Granger, Christopher B, Katz, Jason N, Kontos, Michael C, Kuvin, Jeffrey T, Murphy, Sabina A, Parrillo, Joseph E, Morrow, David A
Publicado em 2013

Rationale and design of REDUCE‐IT: Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial

Por Bhatt, Deepak L., Steg, Ph. Gabriel, Brinton, Eliot A., Jacobson, Terry A., Miller, Michael, Tardif, Jean‐Claude, Ketchum, Steven B., Doyle, Ralph T., Murphy, Sabina A., Soni, Paresh N., Braeckman, Rene A., Juliano, Rebecca A., Ballantyne, Christie M.
Publicado no Clin Cardiol (2017)